We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a ...

Shares of Charles River Laboratories International Inc. CRL rose 1.73% to $106.05 Thursday, on what proved to be an ...

Charles River (CRL) saw its shares surge in the last session with trading volume being higher than average. The latest trend ...

Charles River Laboratories International Inc. closed 60.67% short of its 52-week high of $254.15, which the company achieved ...

Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2025 financial results on Wednesday, May 7th, before the market opens. A conference call has been scheduled to ...

Baird analyst Eric Coldwell raised the firm’s price target on Charles River (CRL) to $118 from $101 and keeps a Neutral rating on the shares.

Charles River Labs faces a 60% loss due to reduced R&D spending, FDA's phase-out of animal testing, and increased competition ...

In trading on Tuesday, shares of Charles River Laboratories International Inc. (Symbol: CRL) entered into oversold territory, hitting an RSI reading of 29.8, after changing hands as low as $105.18 ...

Learn more about whether Avantor, Inc. or Charles River Laboratories International, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Portuguese biotech FairJourney Biologics has acquired South San Francisco antibody R&D facility from Charles River Labs, ...